Skip to main content

Home/ health information/ Group items tagged CHANGES

Rss Feed Group items tagged

pharmacybiz

Rezzayo Breakthrough: MHRA Approves Game-Changing Candidiasis Treatment - 0 views

  •  
    The Medicines and Healthcare products Regulatory Agency (MHRA) on Monday (29 January 2024) approved the medicine Rezzayo (rezafungin) to treat invasive candidiasis, an infection caused by a yeast called Candida. Invasive candidiasis can pose a serious health risk as it can affect the blood, heart, brain, eyes, bones and other parts of the body. Napp Pharmaceuticals Ltd was granted the marketing authorisation for the medicine based on phase 3 clinical trial data. In the randomised, double-blind, controlled study, more than half of the invasive candidiasis patients who were given a weekly dose of rezafungin were cured at day 14. Among 94 patients who were given a daily dose of caspofungin (another antifungal treatment), 57 of them were cured during the same time.
quangbang

Reduce belly fat with Panorama Slim - 1 views

Reduce belly fat with Panorama Slim We'll reveal why this product is the perfect combination of effectiveness and convenience, helping you "set the calendar" for your weight change.

loose weight panorama slim health

started by quangbang on 25 Apr 24 no follow-up yet
pharmacybiz

Aspire Pharma Oncology Leap: Leuprorelin Acetate's Game-Changing Addition - 0 views

  •  
    Aspire Pharma Limited has solidified its position as a leading specialty generics enterprise by adding leuprorelin acetate as a branded generic to its oncology portfolio. Leuprorelin acetate is hormone therapy recommended for patients with high-risk localised, locally advanced, and metastatic prostate cancer, serving as an alternative to surgical castration for locally advanced cases. Used as an alternative to surgical castration for locally advanced prostate cancer, a pre-filled syringe containing 11.25mg of leuprorelin acetate (equivalent to 10.72 mg leuprorelin) is injected subcutaneously into the abdomen. The British pharmaceutical company noted that one of its primary objectives is to seek "new investment opportunities" that brings products and companies into its portfolio, aligning closely with Aspire values and therapeutic focus areas. Prostate cancer is the most common cancer among men in the UK, with an average of over 52,000 men receiving a diagnosis of prostate cancer annually, as per Prostate Cancer UK.
pharmacybiz

Glendale Pharmacy: Under New Ownership - 0 views

  •  
    Since 1990, Glendale Pharmacy in Wooler, Northumberland, has been under the ownership of Andrew Booth, who recently decided to sell it to pursue a well-earned retirement. According to Christie & Co, the community pharmacy has been acquired by Jagraj Randeva, who owns a small portfolio of pharmacies in Ashington and Newcastle upon Tyne. Jagraj was particularly drawn to this pharmacy because of its advantageous, unchallenged location and its strong historical performance. Located near the Cheviot Hills and 17 miles south of Berwick-upon-Tweed, Glendale Pharmacy dispenses an average of 6,600 items per month. Karl Clezy, Director - Pharmacy at Christie & Co, noted that Glendale Pharmacy has seen an improvement in its trading performance since the start of the marketing process, increasing its prescription numbers and providing more additional/enhanced services.
pharmacybiz

NHSE Game-Changing Solution: Artificial Pancreas for Diabetes - 0 views

  •  
    The National Health Services England (NHSE) is poised to revolutionise diabetes management with the introduction of the 'artificial pancreas', also known as the Hybrid Closed Loop system, to treat type 1 diabetes. This pioneering initiative, endorsed by the National Institute of Health Care and Excellence (NICE), represents a global first in healthcare innovation. With 269,095 individuals grappling with type 1 diabetes in England, the Hybrid Closed Loop system is set to cater to tens of thousands of children and adults across the nation. This cutting-edge device operates by seamlessly monitoring blood glucose levels and autonomously adjusting insulin dosage through a pump, by eliminating the need for regular insulin injections. Furthermore, it holds the promise of averting life-threatening hypoglycaemic and hyperglycaemia episodes, mitigating significant risks associated with the condition. To facilitate the identification of beneficiaries, NHSE has allocated a substantial sum of £2.5 million, ensuring that those who could benefit from this innovative solution receive the necessary support.
quangbang

Create new opportunities with Panorama Slim - 1 views

Just because you're fat, you lose a lot of opportunities in life. Are you committed, when you can change it? No one can help you but yourself, this body is yours, whether you want to be beautiful ...

health loose wweight

started by quangbang on 12 Apr 24 no follow-up yet
quangbang

Supports quick and safe weight loss with Panorama Slim - 0 views

Supports quick and safe weight loss with Panorama Slim 1 year of hard training is not equal to 3 weeks of using Panorama Slim, helping you get a slim waist and lose weight without having to think ...

panorama slim loose weight

started by quangbang on 17 Apr 24 no follow-up yet
quangbang

Panorama Slim - The best weight loss support product - 1 views

Panorama Slim - The best weight loss support product Are you searching for an effective and safe weight loss support product? Look no further than Panorama Slim - the top choice for your weight los...

panoramagroup panoramaslim panorama

started by quangbang on 08 Mar 24 no follow-up yet
quangbang

Start your healthy lifestyle with Panorama Slim - 1 views

Start your healthy lifestyle with Panorama Slim Are you ready for a life full of health and confidence? Let Panorama Slim be your reliable companion on the journey to a healthy and understanding li...

panoramaslim panoramagroup

started by quangbang on 05 Mar 24 no follow-up yet
pharmacybiz

Bestway Group Surges with £4.74 Billion Revenue Growth - 0 views

  •  
    Well Pharmacy's parent company, Bestway Group, announced on Wednesday (20 March) that it recorded a five per cent growth in revenues to £4.74 billion for the year ending June 2023, alongside a pre-tax profit of £420.9 million. During the year, the company also completed acquisition of Lexon UK Holdings, a leading pharmaceutical wholesaler serving over 3,000 retail pharmacy customers across the UK and Eire. Furthermore, the Group completed the construction of two cement plants in Pakistan, bringing its total cement manufacturing capacity to 15.3 million tonnes per annum. Sir Anwar Pervez OBE, founder and chairman of Bestway Group, expressed optimism about the new business year and said: "The Group has continued on its growth trajectory in 2023 and we are confident that our businesses will continue to gain share within their respective markets during 2024."
pharmacybiz

NHS Pharmacist Pay: PDA Bold Submission to PRB Sparks Change - 0 views

  •  
    The Pharmacists' Defence Association (PDA) has submitted evidence to the NHS Pay Review Body (PRB), emphasising on the recruitment and retention of NHS pharmacists. It has urged the PRB to help the NHS achieve two important objectives - ensuring that pharmacists can achieve well-rewarded and the service is viewed as an a ppealing alternative by student pharmacists. The PDA suggested that for the NHS to remain competitive, the PRB should focus its pay approach on employees within Bands 5-8 this year. It recognised that the last recommendation from the PRB was a "flat rate increase" and it left those working in the above-mentioned bands feeling "unhappy", which led to the CSP taking strike action over pay for the first time in their history.
quangbang

Panorama Slim - "breathing life" into each product - 1 views

Panorama Slim - "breathing life" into each product To reach customers, each product must go through its own process of action. And with Panorama Slim, it is a story about dedication and meticulousn...

Panorama Slim

started by quangbang on 27 Feb 24 no follow-up yet
robert1488stp

Using Precision Medicine to Address Health Disparities, Webcast | eMedEvents - 0 views

  •  
    Using Precision Medicine to Address Health Disparities is organized by eMedEvents Corporation. Efforts to solve, and overcome health disparities have yielded modest changes.
pharmacybiz

Big News :Boots Sebastian James to Step Down as Managing Director - 0 views

  •  
    Walgreens Boots Alliance (WBA) has officially announced that Sebastian James, the Managing Director of Boots, will be stepping down from his role to pursue a new opportunity in the healthcare sector. James has given notice to leave the company and will remain with Boots until November. The UK pharmacy giant has already begun the search for a new Managing Director. James is set to take on the role of CEO at Veonet, a leading European chain of ophthalmology clinics. During his tenure as Managing Director since 2018, James played a pivotal role in transforming Boots into the UK's leading health and beauty retailer. He oversaw significant growth and innovation, achieving thirteen consecutive quarters of retail market share growth. Most recently, the company announced strong Q3 results in June with growth across all categories.
« First ‹ Previous 461 - 474 of 474
Showing 20 items per page